Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 19;16(9):1447–1460. doi: 10.1093/ecco-jcc/jjac047

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 4. — Biomarker levels of CPa9-HNE, faecal CP, and MRP8/14 serum calprotectin stratified according to endoscopic disease severity based on the A-C] SES-CD for Crohn’s disease [n = 54], D-F], full Mayo score for ulcerative colitis [n = 43], and G-I] MES score for ulcerative colitis [n = 30]. Data are depicted as interquartile range [IQR] with 10–90 percentile. Statistical differences were calculated using one-way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001. CP, calptotectin; ANOVA, analysis of variance; SES-CD, Simple Endoscopic Score for Crohn’s Disease; MES, Mayo Endoscopic Score.